Catalyst Wire Dossier Catalyst Wire Dossier

DaTSCAN Ioflupane (123I) Injection

ioflupane (123I) · GE Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DaTSCAN Ioflupane (123I) Injection, covering 2023-08-02 to 2023-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers. [Phase 1]

See pricing